IXICO (LON:IXI) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened

IXICO plc (LON:IXI)’s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 8.10 and traded as low as GBX 7.50. IXICO shares last traded at GBX 7.67, with a volume of 50,000 shares.

IXICO Stock Performance

The stock’s 50-day moving average is GBX 8.26 and its 200-day moving average is GBX 8.08. The company has a current ratio of 2.83, a quick ratio of 4.90 and a debt-to-equity ratio of 5.22. The stock has a market cap of £17.52 million, a price-to-earnings ratio of -4.10, a P/E/G ratio of -0.38 and a beta of 0.13.

IXICO (LON:IXI) last announced its quarterly earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. IXICO had a negative net margin of 24.98% and a negative return on equity of 16.18%. The business had revenue of GBX 395 million for the quarter. On average, analysts expect that IXICO plc will post -289.3584879 EPS for the current year.

Insider Activity at IXICO

In other IXICO news, insider Mark Warne bought 50,006 shares of IXICO stock in a transaction that occurred on Wednesday, July 15th. The shares were acquired at an average price of GBX 8 per share, for a total transaction of £4,000.48. Corporate insiders own 3.07% of the company’s stock.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.